NEW YORK (GenomeWeb News) – OncoDNA today said that it will collaborate with the Integrated BioBank of Luxembourg to provide physicians in Luxembourg with access to next-generation sequencing-based testing for cancer.

Specifically, OncoDNA was chosen by IBBL as a preferred supplier of molecular diagnostics for lung cancer. The Belgium-based firm will provide its OncoDEEP Dx cancer panel, which includes 50 genes and runs on the Ion Torrent PGM, under the alliance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.